The stock of a littleknown biotech company Intercept Pharmaceuticals Inc nearly quadrupled Thursday after the companys liverdisease drug performed well in a clinical trial marking the biggest oneday stock leap among Nasdaq Composite companies of a similar size since at least   Shares of New Yorkbased Interceptwhich has  employees and no products on the marketclosed Thursday at  on the Nasdaq Stock Market valuing the company at  billion On Wednesday the stock closed at  with a market capitalization
  